The High Value Biorenewables Network (HVB) is one of six Phase II BBSRC Networks in Industrial Biotechnology and Bioenergy (BBSRC) funded for six years from January 2019. Details of all six Phase II NIBB are available at:
https://bbsrc.ukri.org/research/programmes-networks/research-networks/nibb/
High Value Biorenewables builds on the success of the High Value Chemicals from Plants Network, one of 13 Phase I BBSRC NIBB funded from January 2014 – December 2018.
HVB Governance
The Network is managed by an Executive Group working with support from a Management Board. Together, these comprise the Network Leadership Team.
HVB Executive Group members
Professor Ian Graham Network Director |
Centre for Novel Agricultural Products, University of York |
Professor Anne Osbourn Network Co-Director |
John Innes Centre |
Dr Joe Ross Network Co-Director |
University of York & Director of the Biorenewables Development Centre |
Dr Caroline Calvert Associate Director |
University of York |
Dr Joyce Bennett Network Manager |
University of York |
Dr Gail Shuttleworth Network Manager |
University of York |
Stephanie Simpson Network Administrator |
University of York |
HVB Management Board members
Eleanor Binner | Associate Professor, University of Nottingham |
Tim Bowser | Principal, Impact Science Consulting |
Andrew Collis | Synthetic Biochemistry Technical Lead, GSK Pharma Supply Chain |
Paul Fraser | Professor of Biochemistry, Royal Holloway University of London |
Matthew Hodges | Director of Commercial Operations, Oxford Biotrans |
Gary Loake | Group Leader, University of Edinburgh |
Johnathan Napier | Flagship Leader, Rothamsted Research |
Nicola Patron | Director, Earlham DNA Foundry, Earlham Institute |
Simon Saxby (Chair) | Chief Executive Officer, Leaf Expression Systems Ltd |
Monique Simmonds | Deputy Director of Science, Royal Botanic Gardens, Kew |
Helen Townley | University Research Lecturer, University of Oxford |
Rebecca Wood | Open Innovation Coordinator, Croda |
Sanjay Nagarajan | Lecturer, University of Bath |
Ronan Egan | Principal Scientist (Synthetic Biology) Endocryne Ltd |